Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent
1995-06-07
1998-06-09
Prior, Kimberly J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
552653, A61K 3159
Patent
active
057634289
ABSTRACT:
The disclosure is of methods of treating various skin disorders, including skin cancer, with compounds of novel 1.alpha.-hydroxy vitamin D.sub.4 and novel analogues, thereof, including 1,25 dihydroxy vitamin D.sub.4 and 1,24 dihydroxy vitamin D.sub.4. Novel 1.alpha.-hydroxy vitamin D.sub.4 compounds and compounds of novel analogues suitable for use in the treatment of such disorders are also disclosed herein.
REFERENCES:
patent: 2383446 (1945-06-01), Calcott et al.
patent: 3697559 (1972-10-01), DeLuca et al.
patent: 3741996 (1973-06-01), DeLuca et al.
patent: 4195027 (1980-03-01), DeLuca et al.
patent: 4202829 (1980-05-01), DeLuca et al.
patent: 4260549 (1981-04-01), DeLuca et al.
patent: 4362710 (1982-12-01), Watanabe
patent: 4555364 (1985-11-01), DeLuca et al.
patent: 4661294 (1987-04-01), Holick et al.
patent: 4689180 (1987-08-01), DeLuca et al.
patent: 4728643 (1988-03-01), Holick et al.
patent: 4866048 (1989-09-01), Calverley et al.
patent: 5157135 (1992-10-01), Tsuji et al.
patent: 5185150 (1993-02-01), DeLuca et al.
F. Sato et al., Biochim. Biophys. Acta, vol. 1091 (1991) pp. 188-192.
E. Braunwald et al., Harrison's Principles of Internal Medicine: Part Eleven, "Disorders of Bone and Mineral Metabolism," Chapter 335, McGraw-Hill, New York, 1987, pp. 1860-1865.
Grab, W., Z. Physiol. Chem., 243:63-89 (1936).
McDonald, F. G., J. Biol. Chem., 114:IVX (1936).
Windaus, A. and Trautmann, G., Z. Physiol. Chem., 247:185-188 (1937).
DeLuca et al., Arch. Biochem, Biophys., 124:122-128 (1968).
Merck Index, S. Budavari (ed.), 11th ed., Merck & Co., Rahway, N.J. (1989) pp. 1579, #9930.
Barton et al., JCS Perkin I, 1976, 821-826.
Paaren et al., J. Org. Chem., 1980, 45:3253.
Wientroub, S. et al., "The Dichotomy in the Effects of 1,25 dihydroxy vitamin D.sub.3 and 24,25 dihydroxy vitamin D.sub.3 on Bone Gamma-Carboxyglutamic Acid-Containing Protein in Serum and Bone in vitamin D-Deficient Rats," Calcif, Tissue Int. (1987) 40:166-172.
Sjoden, G. et al., Proc. Soc. Experimental Biol. Med., 178:432-436 (1985).
Strugnell et al., Biochem. Pharm. vol. 40:333-341 (1990).
Martin and DeLuca, Am. J. Physiol. 216:1352-1359 (1967).
Kocienski, P. J., Lythgoe, B. and Ruston, S., J.C.S. Perkins I, 1290-1293 (1979).
Tsuji, M. et al., Bull. Chem. Soc. Jpn., vol. 63, No. 8, 2233-2238 (1990).
Crump, D. R., Williams, D. H. and Pelc, B., J.C.S. Perkins Trans. I, 2731-2733 (1973).
Chemical Abstracts, vol. 113, No. 1, 2 Jul. 1990, Columbus, Ohio, US; abstract No. 6683y, Y. Tachibana, `Preparation of 1beta-hydroxyvitamin D.sub.2 and D.sub.3, ` p. 6688; col. 2; *abstract* & JP-A-02 011 563 (nisshin Flour Milling Co.).
Chemistry Letters, No. 8, Aug. 1985, Tokyo, JP, pp. 1131-1132, H. Nemeto et al., `A steroselective synthesis of 1 alpha-hydroxy-vitamin D.sub.3 `; *the whole document*.
Bishop Charles W.
Knutson Joyce C.
Bone Care International, Inc.
Prior Kimberly J.
Welch Teresa J.
LandOfFree
Methods of treating skin disorders with novel 1a-hydroxy vitamin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating skin disorders with novel 1a-hydroxy vitamin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating skin disorders with novel 1a-hydroxy vitamin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2199267